Published in J Neurosci on August 01, 2002
Effects of a formal exercise program on Parkinson's disease: a pilot study using a delayed start design. Parkinsonism Relat Disord (2013) 2.05
Behavioral tests for preclinical intervention assessment. NeuroRx (2006) 1.75
Delaying mobility disability in people with Parkinson disease using a sensorimotor agility exercise program. Phys Ther (2009) 1.36
Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease. Exp Brain Res (2005) 1.32
Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology (2011) 1.28
Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance. Prog Neurobiol (2014) 1.13
Neurobiology of rehabilitation. Ann N Y Acad Sci (2004) 1.06
Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits. Mol Ther (2008) 1.05
Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. Parkinsonism Relat Disord (2008) 1.05
A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease. J Commun Disord (2010) 0.99
Dopaminergic neuronal injury in the adult rat brain following neonatal exposure to lipopolysaccharide and the silent neurotoxicity. Brain Behav Immun (2010) 0.96
Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. J Mot Behav (2008) 0.95
Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behav Brain Res (2010) 0.92
Running wheel activity restores MPTP-induced functional deficits. J Neural Transm (Vienna) (2010) 0.90
Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease. J Commun Disord (2011) 0.90
Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Neurobiol Dis (2011) 0.89
Targeted exercise therapy for voice and swallow in persons with Parkinson's disease. Brain Res (2010) 0.88
α4β2 Nicotinic receptors play a role in the nAChR-mediated decline in L-dopa-induced dyskinesias in parkinsonian rats. Neuropharmacology (2013) 0.87
Effect of exercise on dopamine neuron survival in prenatally stressed rats. Metab Brain Dis (2009) 0.84
Modular ankle robotics training in early subacute stroke: a randomized controlled pilot study. Neurorehabil Neural Repair (2014) 0.81
Exercise alters resting-state functional connectivity of motor circuits in parkinsonian rats. Neurobiol Aging (2014) 0.81
Exercise-induced rescue of tongue function without striatal dopamine sparing in a rat neurotoxin model of Parkinson disease. Behav Brain Res (2013) 0.80
Interleukin-1 receptor antagonist reduces neonatal lipopolysaccharide-induced long-lasting neurobehavioral deficits and dopaminergic neuronal injury in adult rats. Int J Mol Sci (2015) 0.80
Beyond neuroprotection to brain repair: exploring the next frontier in clinical neuroscience to expand the therapeutic window for stroke. Transl Stroke Res (2010) 0.79
An evidence-based exercise regimen for patients with mild to moderate Parkinson's disease. Brain Sci (2013) 0.79
Neonatal exposure to lipopolysaccharide enhances accumulation of α-synuclein aggregation and dopamine transporter protein expression in the substantia nigra in responses to rotenone challenge in later life. Toxicology (2013) 0.78
Rehabilitation and Parkinson's disease. Parkinsons Dis (2012) 0.78
Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats. Neuropharmacology (2010) 0.78
Promoting exercise in Parkinson's disease through community-based participatory research. Neurodegener Dis Manag (2011) 0.77
The effects of brain stimulation of subthalamic nucleus surgery on gait and balance performance in Parkinson disease. A pilot study. Arch Med Sci (2014) 0.77
Cueing training in persons with Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 0.75
The effect of red grape juice and exercise, and their combination on parkinson(')s disease in rats. Avicenna J Phytomed (2012) 0.75
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats. Neuroscience (2016) 0.75
Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95
Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev (2006) 4.02
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91
Neurobiology of exercise. Obesity (Silver Spring) (2006) 3.39
Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci (2003) 3.30
Amyloid imaging in mild cognitive impairment subtypes. Ann Neurol (2009) 2.66
A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone. Proc Natl Acad Sci U S A (2010) 2.57
Behavioral tests after intracerebral hemorrhage in the rat. Stroke (2002) 2.46
Transgenerational epigenetic imprints on mate preference. Proc Natl Acad Sci U S A (2007) 2.42
A role for alpha-synuclein in the regulation of dopamine biosynthesis. J Neurosci (2002) 2.37
A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods (2002) 2.35
Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg (2004) 2.31
Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci (2009) 2.29
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci (2007) 2.28
Automating ultrasonic vocalization analyses: the WAAVES program. J Neurosci Methods (2013) 2.13
Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res (2006) 2.02
Animal models of neurological deficits: how relevant is the rat? Nat Rev Neurosci (2002) 1.96
The essential nature of sharing in science. Sci Eng Ethics (2010) 1.87
Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg (2006) 1.82
Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma (2007) 1.76
Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J Neurotrauma (2005) 1.74
Industrial toxicants and Parkinson's disease. Neurotoxicology (2012) 1.65
Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res (2003) 1.57
The vermicelli handling test: a simple quantitative measure of dexterous forepaw function in rats. J Neurosci Methods (2008) 1.54
Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF. J Neurochem (2003) 1.53
Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats. Behav Brain Res (2008) 1.52
Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav Brain Res (2007) 1.49
Iron is essential for neuron development and memory function in mouse hippocampus. J Nutr (2009) 1.47
Parkinson's disease and pesticides: a toxicological perspective. Trends Pharmacol Sci (2008) 1.47
Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol (2002) 1.46
Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J Neurochem (2007) 1.44
Use-dependent behavioral and neurochemical asymmetry in MPTP mice. Neurosci Lett (2006) 1.43
Testing forelimb placing "across the midline" reveals distinct, lesion-dependent patterns of recovery in rats. Exp Neurol (2005) 1.39
Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res (2002) 1.39
Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats. Behav Neurosci (2009) 1.38
Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol Sci (2005) 1.38
Memory processes governing amphetamine-induced psychomotor sensitization. Neuropsychopharmacology (2002) 1.36
Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke (2009) 1.36
Intracerebral hemorrhage in mice: model characterization and application for genetically modified mice. J Cereb Blood Flow Metab (2004) 1.35
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. J Neurochem (2013) 1.34
Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Mol Neurobiol (2009) 1.33
Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Methods (2003) 1.32
Wild-type LRRK2 but not its mutant attenuates stress-induced cell death via ERK pathway. Neurobiol Dis (2008) 1.29
Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicol Sci (2006) 1.27
Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. FASEB J (2006) 1.26
Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol (2007) 1.24
Can the brain be protected through exercise? Lessons from an animal model of parkinsonism. Exp Neurol (2003) 1.22
Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg (2004) 1.22
Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J Neurosurg (2008) 1.21
Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Res (2006) 1.21
A simple modification of the water maze test to enhance daily detection of spatial memory in rats and mice. J Neurosci Methods (2006) 1.20
Pulse wave velocity is associated with β-amyloid deposition in the brains of very elderly adults. Neurology (2013) 1.18
Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Immunol (2008) 1.18
Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Sci (2006) 1.17
Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats. J Nutr (2007) 1.17
Repeated intravenous cocaine experience: development and escalation of pre-drug anticipatory 50-kHz ultrasonic vocalizations in rats. Behav Brain Res (2010) 1.16
Protective effects and mechanisms of sirtuins in the nervous system. Prog Neurobiol (2011) 1.14
Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis. J Neurochem (2008) 1.14
Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor. J Neurochem (2004) 1.14
A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation. J Neurochem (2007) 1.12
Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter. Neurobiol Dis (2007) 1.11
Cognitive trajectories associated with β-amyloid deposition in the oldest-old without dementia. Neurology (2013) 1.11
Alcohol-induced retrograde memory impairment in rats: prevention by caffeine. Psychopharmacology (Berl) (2008) 1.10
Altered vesicular dopamine storage in Parkinson's disease: a premature demise. Trends Neurosci (2008) 1.10
Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol Sci (2006) 1.10
Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. J Neurosci (2005) 1.10
Therapeutic effects of erythropoietin on histological and functional outcomes following traumatic brain injury in rats are independent of hematocrit. Brain Res (2009) 1.09
Stress-induced Parkinson's disease: a working hypothesis. Physiol Behav (2002) 1.08
Acute exposure to aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicol Lett (2004) 1.07
VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease. Parkinsons Dis (2011) 1.07
An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behav Brain Res (2005) 1.07
The missing variable: ultrasonic vocalizations reveal hidden sensitization and tolerance-like effects during long-term cocaine administration. Psychopharmacology (Berl) (2011) 1.06
Helping students get into graduate school. J Undergrad Neurosci Educ (2004) 1.06
Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training. Parkinsonism Relat Disord (2008) 1.05
Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. J Neurosci Res (2008) 1.04
Constraint-induced movement therapy. Stroke (2004) 1.04
Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress. J Neurosci Res (2006) 1.04
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B. Alzheimers Dement (2012) 1.03
Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma (2010) 1.03
Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK. J Neurosci Res (2003) 1.03
Polyethylene glycol rapidly restores axonal integrity and improves the rate of motor behavior recovery after sciatic nerve crush injury. J Neurophysiol (2010) 1.02
Behavioral phenotyping of mouse models of Parkinson's disease. Behav Brain Res (2010) 1.02
Cocaine deprivation effect: cue abstinence over weekends boosts anticipatory 50-kHz ultrasonic vocalizations in rats. Behav Brain Res (2010) 1.01
Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Dis (2008) 1.01
Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system. Brain Res (2008) 1.01
The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochem Pharmacol (2008) 1.00
Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice. Brain Res (2007) 0.99
Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol Appl Pharmacol (2005) 0.99
Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol Appl Pharmacol (2009) 0.99